baber/WOPTO huggingface dataset:
Patent AU-2004251144-B2 (AU)
Title: Low temperature liquid polythioether polymers
Inventor: RAO CHANDRA BHUSHAN
IPC: C08G75/04
Filed: 2004-06-04
Granted: 2007-05-10
Abstract: Polythioether polymers, curable compositions of polythioether polymers, the process of making polythioether polymers, and the use of polythioether polymers in sealants, wherein the polythioether polymers and curable compositions are liquid at a temperature of 20° C. or less, are disclosed.
Patent AU-2004251751-B2 (AU)
Title: Coffee with enhanced flavor provided by 3,7-dimethylocta-1,6-dien-3-ol
Inventor: NORTON MARK RICHARD THOMAS
IPC: A23L27/00
Filed: 2004-06-25
Granted: 2010-02-11
Abstract: A coffee product and process are provided which produce a coffee product having elevated levels of 3,7-dimethylocta-1,6-dien-3-ol. In various forms, the coffee product is dry roast and ground coffee or a dry soluble coffee product such as a powder or granule form. The process includes adding 3,7-dimethylocta-1,6-dien-3-ol to roast and ground coffee or a soluble coffee to produce an enhanced coffee flavor beverage, or to an extract or solution thereof.
Patent AU-2005209292-B2 (AU)
Title: Anchoring element for use in bone
Inventor: CANTER STANTON R
IPC: A61C8/00
Filed: 2005-01-28
Granted: 2011-04-28
Abstract: An anchoring element for use in bone has a proximal end and a distal end. The distal end may be embedded in bone with the proximal end exposed. An abutment surface is disposed toward the proximal end. The anchoring element includes four surfaces that define the distal end. A generally cylindrical first surface defines an exterior of the anchoring element and includes a first external thread having a pitch. An annular second surface is disposed toward the distal end and joined to the first surface along an outer circumference of the second surface. A third surface concentric with the first surface is joined to the second surface along an inner circumference of the second surface. A fourth surface disposed between the distal end and the proximal end of the first surface is joined to the third surface along an outer circumference of the fourth surface.
Patent AU-2005252401-B2 (AU)
Title: Cholesterol-producing yeast strains and uses thereof
Inventor: SPAGNOLI ROBERTO
IPC: A61K51/04
Filed: 2005-05-02
Granted: 2012-04-05
Abstract: The invention concerns the production of cholesterol in organisms of the kingdom. More particularly, the invention concerns genetically modified independently producing cholesterol from a simple carbon source. The invention also concerns the use of the inventive for producing non-marked and marked cholesterol.
Patent AU-2005279351-B2 (AU)
Title: Alternative synthesis of renin inhibitors and intermediates thereof
Inventor: MICKEL STUART JOHN
IPC: C07D207/26
Filed: 2005-08-30
Granted: 2009-04-23
Abstract: The present invention relates to synthetic routes to prepare a compound of the formula   
wherein R 1  is halogen, C 1-6 halogenalkyl, C 1-6 alkoxy-C 1-6 alkyloxy or C 1-6 alkoxy-C 1-6 alkyl; R 2  is halogen, C 1-4 alkyl or C 1-4 alkoxy; R 3  and R 4  are independently branched C 3-6 alkyl; and R 5  is cycloalkyl, C 1-6 alkyl, C 1-6 hydroxyalkyl, C 1-6 alkoxy-C 1-6 alkyl, C 1-6 alkanoyloxy-C 1-6 alkyl, C 1-6 aminoalkyl, C 1-6 alkylamino-C 1-6 alkyl, C 1-6 dialkylamino-C 1-6 alkyl, C 1-6 alkanoylamino-C 1-6 alkyl, HO(O)C-C 1-6 alkyl, C 1-6 alkyl-O-(O)C-C 1-6 alkyl, H 2 N-C(O)-C 1-6 alkyl, C 1-6 alkyl-HN-C(O)-C 1-6 alkyl or (C 1-6 alkyl) 2 N-C(O)-C 1-6 alkyl; or a pharmaceutically acceptable salt thereof as well as key intermediates obtained when following these routes as well as their preparation.
Patent AU-2005336458-B2 (AU)
Title: Anthelmintic formulations
Inventor: ABDUL RAZZAK MAJID HAMEED
IPC: A01N43/04
Filed: 2005-09-15
Granted: 2012-01-12
Abstract: This invention relates to the preparation of veterinary anthelmintic formulations including triclabendazole in solution, particularly for the treatment of parasitic infections such as fasciolisis, and particularly for administration to an animal in the form of a pour-on. The solutions include triclabendazole dissolved in a solvent system including at least one solvent selected from 2-pyrrolidone and liquid polyethylene glycol. Additional solvents may also be included. The present invention is advantageous as triclabendazole can be included in solution up to a concentration of about 60% w/v allowing for an effective dose to be delivered to the animal in a volume of 25 ml or less.
Patent AU-2006226304-B2 (AU)
Title: Process for microbial production of a valuable compound
Inventor: GAUDIN PHILIPPE THIERRY FRANCOIS
IPC: C12P21/00
Filed: 2006-03-23
Granted: 2012-03-15
Abstract: The present invention relates to a process for the production of a valuable compound by cultivation of a microorganism comprising cultivating the microorganism in a medium wherein all nutrients are provided in excess over the whole cultivation period and wherein a suitable amount of oxygen is fed to the culture to maintain the culture under conditions of oxygen limitation.
Patent AU-2006249014-B2 (AU)
Title: Steam unit with external fastening, including a tank for frothing milk and heating beverages, for a machine for espresso beverages
Inventor: STEFANO TONELLI
IPC: A47J31/44
Filed: 2006-05-15
Granted: 2011-06-30
Abstract: A steam unit, in particular for a machine for espresso beverages, including a supporting island (1, 2) with external fastening (5, 6), which connects removably to the machine (71) ; a tank (4) for frothing milk, the base (20) of which connects removably to the supporting island (2) , which in turn comprisesan electro/hydraulic circuit to deliver steam from the machine to the tank, by means of the connection (8) at the base (20) of the tank, said tank (4) including an upper part (22, 23, 24) for heating and emulsifying the beverages.
Patent AU-2006270499-B2 (AU)
Title: Fistula graft with deformable sheet-form material
Inventor: GRAHAM MATTHEW R
IPC: A61K35/22
Filed: 2006-04-28
Granted: 2011-10-06
Abstract: Described are medical products, systems, and methods for treating fistulae having a primary opening, such as in the alimentary canal. Certain methods of the invention include providing an implantable material including a compliant sheet form biocompatible material, and forcing this sheet form biocompatible material into the primary opening so as to deform the sheet form biocompatible material to conform to and block the primary opening. The biocompatible material preferably comprises a remodelable material, for example, a remodelable extracellular matrix material such as submucosa .
Patent AU-2006283365-B2 (AU)
Title: Surgical scaffold
Inventor: KANG NORBERT
IPC: A61F2/18
Filed: 2006-08-25
Granted: 2012-05-17
Abstract: A scaffold for reshaping an ear or a nose, the scaffold being configured to be i) attached to the cartilaginous portion of an ear or ii) attached to the cartilaginous portion of a nose, wherein the scaffold is formed at least in part from a shape-memory material and/ or a plastic material and is capable of transforming from a first configuration to a second, pre-programmed configuration.
Patent AU-2006321287-B2 (AU)
Title: Compositions and methods relating to treatment of cancer and infectious diseases
Inventor: TOOMEY DEIRDRE
IPC: A61K39/00
Filed: 2006-12-01
Granted: 2013-05-09
Abstract: The present invention provides methods for modulating an immune response by administering a composition comprising a Toll-iike receptor agonist and an immune mediator which downregufates the expression of the anti-inflammatory cytokine IL-10 and upregulates the expression of the pro-inflammatory cytokine IL-12. The methods can be used to provide therapeutic treatment for cancerous conditions and infectious diseases.
Patent AU-2006332448-B2 (AU)
Title: Waste disposal during pit mining
Inventor: STONE PETER MITCHELL
IPC: E21C41/00
Filed: 2006-12-20
Granted: 2012-11-08
Abstract: A method, apparatus and computer program for pit mining with waste dumping is disclosed, in which material is extracted from an open pit and some of that material is sent to waste. The method optimises a joint extraction and waste refill schedule. The method defines a road network (14) having a plurality of nodes 16 with at least some of the nodes (16a) defining entry points to a plurality of waste dumps. The waste dumps are either in pit waste dumps or external waste dumps. Waste material is moved along the road network from a location in the pit to an entry node relating to one of the waste dumps and deposited at the waste dump. Material can be moved from external waste dumps to in pit waste dumps. The in pit waste dumps are determined from a block model providing a joint extraction and refill schedule, and refill aggregate spaces are determined which comprise aggregates of blocks which have already been mined so that material is removed from those blocks to define a refill aggregate space which is then available to act as a waste dump for return of waste material to the pit.
Patent AU-2007209126-B2 (AU)
Title: Pyrimidine derivatives
Inventor: LAMBERT-VAN DER BREMPT CHRISTINE MARIE PAUL
IPC: C07D405/12
Filed: 2007-01-25
Granted: 2012-01-19
Abstract: The invention concerns benzamide compounds of Formula (I), or a pharmaceutically acceptable salt thereof, where R, ring A, n, R, and R are as defined in the description. The present invention also relates to processes for the preparation of such compounds, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of tumours or other proliferative conditions which are sensitive to the inhibition of EphB4, and/or EphA2 and/or Src kinases.
Patent AU-2007211356-B2 (AU)
Title: Galactosidase with alpha-galactosyltransferase activity
Inventor: GOULAS ATHANASIOS K
IPC: C12N9/38
Filed: 2007-01-23
Granted: 2012-05-17
Abstract: The present invention concerns a β-galactosidase with transgalactosylating activity isolated from Bifidobacterium bifidum. The β-galactosidase is capable of converting lactose to a mixture of oligosaccharides which are β-linked and unexpectedly produces the α-linked disaccharide galactobiose. The mixture may be incorporated into numerous food products or animal feeds for improving gut health by promoting the growth of bifidobacteria in the gut, and repressing the growth of the pathogenic microflora.
Patent AU-2007215120-B2 (AU)
Title: Method for multi-modal communications in a VoIP environment
Inventor: JOHN RILEY
IPC: H04L29/06
Filed: 2007-02-13
Granted: 2011-07-21
Abstract: A system and method for provisionable, multi-modal communications, including detecting a provisioning condition, selecting a communications mode based on the provisioning condition from a first usage mode, a second usage mode, and a third usage mode, and displaying an interface corresponding to the selected communications mode. The first usage mode includes a first communications channel supporting a first communication data consisting of instant messages (IM) and in-network voice data. The second usage mode includes a second communications channel supporting a second communication data consisting of IM, in-network voice data and out-of-network voice data. The third usage mode includes a second communications channel supporting a third communication data comprising video data.
Patent AU-2007216746-B2 (AU)
Title: Mops
Inventor: XUE LIN ZHU
IPC: A47L13/258
Filed: 2007-09-12
Granted: 2011-07-14
Abstract: A mop (1) is provided that has a generally elongate mop pad (5) that is squeezable by user operable squeezing mechanism (7). When the mop pad is squeezed, it is folded generally about its center to form a generally "U" shape. The user operable squeezing mechanism (7) then squeezes the opposed faces against each other. The squeezing mechanism (7) cooperates with the mop pad (5) to also tilt the mop pad (5) from a position where the mop pad (5) is extending generally orthogonal to a longitudinal axis of a mop handle (3), to a position where the mop pad (5) is inclined relative to the longitudinal axis of the mop handle (3) and so when the mop handle (3) is inclined to a planar surface to be cleaned, the mop pad (5) can better engage with the planar surface to be cleaned than if the mop pad (5) were not tilted. H \Pnywa \Keep\spec\P74157.AU - Decr doc 12/09/07
Patent AU-2007227813-B2 (AU)
Title: Improved protofibril selective antibodies and the use thereof
Inventor: GELLERFORS PAR
IPC: A61P25/28
Filed: 2007-03-23
Granted: 2012-09-27
Abstract: The present invention pertains to the prevention, treatment and diagnosis of neurodegenerative diseases, in particular Alzheimer's disease, and other similar disease. More specifically to high affinity antibodies selective for amyloid beta protein (Aβ) in its protofibril conformation and of IgG class and IgGl or IgG4 subclass or combinations thereof or mutations thereof, retaining high Fc receptor binding and low Cl(CIq) binding, effective in clearance of Aβ protofibrils and with reduce risk of inflammation.
Patent AU-2007231639-B2 (AU)
Title: Long term bioabsorbable barbed sutures
Inventor: STOPEK JOSHUA
IPC: A61L17/10
Filed: 2007-10-24
Granted: 2014-01-23
Abstract: LONG TERM BIOABSORBABLE BARBED SUTURES Abstract Barbed surgical sutures (10) and a method of forming a barbed surgical suture (10) from a degradable material are provided having a degradation rates tailored to 5 provide the suture (10) with a desired mass loss profile.
Patent AU-2007240443-B2 (AU)
Title: Inhibitors of c-fms kinase
Inventor: DESJARLAIS RENEE LOUISE
IPC: A61P13/00
Filed: 2007-04-18
Granted: 2012-11-01
Abstract: The invention is directed to compounds of Formula (I): wherein Z, X, J, R and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula (I), are also provided.
Patent AU-2007262939-B2 (AU)
Title: Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
Inventor: CAUMONT-BERTRAND KARINE
IPC: A61P3/04
Filed: 2007-06-21
Granted: 2012-04-05
Abstract: The present invention relates to substituted 1,3-diphenylpropane derivatives, to the pharmaceutical compositions containing them and to the therapeutic uses thereof, in particular in the fields of human and animal health.
Patent AU-2007264252-B2 (AU)
Title: Spatially-resolved measurement method for the detection of melanin in fluorophor mixtures in a solid sample
Inventor: MATTHIAS SCHOLZ
IPC: G01N21/64
Filed: 2007-06-17
Granted: 2011-10-13
Abstract: Known measurement methods use excitation wavelengths of 800 nm at ultra-short pulse lengths of 100 fs, with repetition rates of 80 MHZ and power densities of 100 GW/cm. In such methods, simultaneous two-photon and three-photon excitations in the dangerous UV-C region are sometimes obtained. With the resulting fluorescence spectrum, neither the melanin in general, nor individual melanin types, can be clearly identified from the fluorophor mixture, as would be necessary for determining malignant melanomas in skin tissue. In addition, there is an acute risk of bleaching out and of carcinogenic action on the sample. To improve the differentiation capability for the various melanin types and to avoid the risks mentioned, the method according to the invention uses wavelengths of up to 900nm at pulse lengths of up to 2ns and single pulses with power densities less than 1 GW/cm. With the characteristic maxima of 475 nm for and 575 nm for , the elimination of the flavin fluorescence and the effect of the significant reduction in the total fluorescence in malignant melanomas in skin tissue, the unequivocal identification of these canbe achieved with the technique.
Patent AU-2007274081-B2 (AU)
Title: Drug delivery polymer with hydrochloride salt of clindamycin
Inventor: BOYD LYNN
IPC: A61K9/00
Filed: 2007-07-12
Granted: 2012-08-02
Abstract: One embodiment provides an insert, which includes a non-degradable hydrogel matrix and clindamycin hydrochloride in contact with the matrix, wherein the insert is suitable for mammalian intravaginal, buccal, or intrarectal use. Methods of using and making the insert are also provided.
Patent AU-2007285483-B2 (AU)
Title: Administration of cells and cellular extracts for rejuvenation
Inventor: RUNHILD GAMMELSAETER
IPC: A61K35/36
Filed: 2007-05-11
Granted: 2011-12-22
Abstract: The invention describes methods and agents for improving cosmetic appearance, for promoting, improving or restoring health of cells and tissues, preferably skin, and more preferably, for restoring aged or damaged skin to a healthy appearance. This invention relates to the use of cells and cellular extracts in rejuvenation and healing technologies thereby improving healing and regeneration of all bodily tissues and organs. The present invention relates to compositions and methods of managing, preventing, and treating scars. The invention also relates to prevention of deterioration, damage and malfunction of cells and tissues, and to promote, improve or exceed cellular function in order to promote, improve and exceed appearance, vitality and health. In some embodiments, the invention relates to compositions of cells, eggs, cell extracts, egg extracts, and extract components such as purified nucleic acids, polypeptides, lipids, carbohydrates or other natural products. Said components can also be synthesized. In other embodiments, the cells are differentiable cells preferably stem cells or eggs. In some embodiments, compositions are used in a method that comprises application of compositions to tissues, including skin and/or wounds after removal of tissue surface layers. In other embodiments, the invention relates to methods of dedifferentiation of cells and/or dedifferentiation followed by differentiation. In other embodiments, the invention relates to managing, preventing, and treating skin diseases.
Patent AU-2007333330-B2 (AU)
Title: Location of wideband OFDM transmitters with limited receiver bandwidth
Inventor: MIA RASHIDUS S
IPC: G01S5/02
Filed: 2007-11-28
Granted: 2011-08-04
Abstract: A system for locating wireless transmitters employing an Orthogonal Frequency Division Multiplexing (OFDM) digital modulation scheme. The OFDM scheme comprises transmitting signal components over narrowband frequency channels spanning a wideband channel. The system includes a first receiving system configured to receive a fraction of the signal components transmitted by a first wireless transmitter to be located in a fraction of the narrowband frequency channels, and to process the fraction of the signal components to derive location related measurements. The system further includes at least a second receiving system configured to receive the fraction of the signal components transmitted by the first wireless transmitter, and to process this fraction of the signal components to derive location related measurements. The system also includes a processing system configured to use location related measurements from the first and second receiving systems to compute the location of the wireless transmitter.
Patent AU-2007353481-B2 (AU)
Title: H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance
Inventor: HO YUEN FERN
IPC: G01N33/53
Filed: 2007-05-11
Granted: 2013-08-29
Abstract: The invention provides monoclonal antibodies and related binding proteins that bind specifically to the envelope glycoprotein of H5 subtypes of avian influenza virus ("AIV"). The monoclonal antibodies and related binding proteins are useful for the detection of H5 subtypes of AIV, including the pathogenic H5N1 subtypes. Virus may be detected in formalin preserved, paraffin embeded specimens as well as frozen specimens and biological fluids. Accordingly, the invention provides means for the diagnosis and surveillance of dangerous viral infections.
Patent AU-2008200048-B2 (AU)
Title: A content filtering system for a mobile communication device and method of using same
Inventor: DENNIS MEGAN TEI
IPC: H04W88/12
Filed: 2008-01-06
Granted: 2012-02-09
Abstract: Abstract A method of controlling access to content from a mobile client device, the mobile client device being communicably connected to a server device via a communication link, and the method including the steps of: (i) receiving in the mobile client device, an input indicative of the content; (ii) thereafter, processing the received input, wherein said processing includes the mobile client device determining if the received input meets an access criteria, whereby, the mobile client device selectively provides access to the content if the access criteria is determined to have been met.
Patent AU-2008202185-B2 (AU)
Title: A System for antibody expression and assembly
Inventor: ANDERSEN DANA C
IPC: C12N15/13
Filed: 2008-05-16
Granted: 2011-10-27
Abstract: The present invention provides methods and compositions for expression and production of recombinant antibodies in a host cell system, such as prokaryotic and eukaryotic expression systems. Particularly contemplated are recombinant systems for temporally separated expression of light chain and heavy chain of antibodies. The antibody products including antibody fragments can be used in various aspects of biological research, diagnosis and medical treatment.
Patent AU-2008219433-B2 (AU)
Title: Methods and systems for certifying provenance of alcoholic beverages
Inventor: VOGT ERIC
IPC: G06Q10/00
Filed: 2008-02-14
Granted: 2013-10-03
Abstract: A system for certifying provenance of an alcoholic beverage includes a radio-frequency identification tag and a server. The radio-frequency identification (RFID) tag, associated with a bottle containing an alcoholic beverage, periodically measures and stores a plurality of values of an environmental condition of the bottle. The server receives the plurality of measured values for analysis and provides, via a user interface, a description of a provenance of the alcoholic beverage. In another aspect, a neck seal including a neck seal identification number and an invisible security taggant is attached to the bottle. A first reader scans the neck seal, detects the presence of the security taggant, and authenticates the neck seal. A second reader retrieves a bottle tag number from an RFID tag. The server authenticates the contents of the bottle responsive to identifying an association between the neck seal identification number and the bottle tag number.
Patent AU-2008233256-B2 (AU)
Title: Transgenic animal models of disease
Inventor: PRATHER RANDALL
IPC: C12N15/63
Filed: 2008-03-05
Granted: 2013-06-27
Abstract: The present invention provides transgenic, large non-human animal models of diseases and conditions, as well as methods of using such animal models in the identification and characterization of therapies for the diseases and conditions.
Patent AU-2008248905-B2 (AU)
Title: Two-step temperature profile for the propagation of viruses
Inventor: MUNDT WOLFGANG
IPC: C12N7/00
Filed: 2008-04-30
Granted: 2014-05-29
Abstract: The present invention provides a method for the production of a virus. The method includes providing a host cell that has been infected by the virus and cultivating the infected host cell at two different temperatures. The virus produced by the cultivation steps is subsequently collected. By using the dual temperature cultivation process, high titer and improved purity can be obtained.